Veterinary Medicines

UNISTRAIN PRRS lyophilisate and solvent for suspension for injection for pigs

Authorised
  • Porcine reproductive and respiratory syndrome virus, type 1, strain VP-046 BIS, Live
  • Water for injection
Download as PDF

Product identification

Medicine name:
UNISTRAIN PRRS lyophilisate and solvent for suspension for injection for pigs
UNISTRAIN PRRS λυοφιλοποιημένο υλικό και διαλύτης για ενέσιμο εναιώρημα για χοίρους
Active substance:
  • Porcine reproductive and respiratory syndrome virus, type 1, strain VP-046 BIS, Live
  • Water for injection
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine reproductive and respiratory syndrome virus, type 1, strain VP-046 BIS, Live
    3162.27
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Water for injection
    1.00
    other
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Package description:
  • Solvent: Colourless Type II glass vial (50, 100 and 250 ml) or PET vials (50, 100 and 250 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intradermal use: Cardboard box containing 10 vials with 20 ml of solvent.
  • Solvent: Colourless Type I glass vial (10 ml), or PET vials (10 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intradermal use: Cardboard box containing 10 vials with 10 ml of solvent.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Solvent: Colourless Type II glass vial (50, 100 and 250 ml) or PET vials (50, 100 and 250 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 1 vial with 125 doses of freeze-dried powder and 1 vial with 25 ml of solvent.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Solvent: Colourless Type I glass vial (20 ml), or PET vials (20 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 1 vial with 100 doses of freeze-dried powder and 1 vial with 20 ml of solvent.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Solvent: Colourless Type I glass vial (10 ml), or PET vials (10 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 1 vial with 50 doses of freeze-dried powder and 1 vial with 10 ml of solvent.
  • Solvent: Colourless Type II glass vial (250 ml) or PET vials (250 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 10 vials with 250 ml of solvent.
  • Solvent: Colourless Type II glass vial (250 ml) or PET vials (250 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 10 vials with 200 ml of solvent.
  • Solvent: Colourless Type II glass vial (100 ml) or PET vials (100 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 10 vials with 100 ml of solvent.
  • Solvent: Colourless Type II glass vial (50 ml) or PET vials (50 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 10 vials with 50 ml of solvent.
  • Solvent: Colourless Type I glass vial (20 ml), or PET vials (20 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular or Intradermal use: Cardboard box containing 10 vials with 20 ml of solvent.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular or Intradermal use: Cardboard box containing 10 vials with 125 doses of freeze-dried powder.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular or Intradermal use: Cardboard box containing 10 vials with 100 doses of freeze-dried powder.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular or Intradermal use: Cardboard box containing 10 vials with 50 doses of freeze-dried powder.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 10 vials with 25 doses of freeze-dried powder.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 10 vials with 10 doses of freeze-dried powder.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Solvent: Colourless Type II glass vial (250 ml) or PET vials (250 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 1 vial with 125 doses of freeze-dried powder and 1 vial with 250 ml of solvent.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Solvent: Colourless Type II glass vial (250 ml) or PET vials (250 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 1 vial with 100 doses of freeze-dried powder and 1 vial with 200 ml of solvent.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Solvent: Colourless Type II glass vial (100 ml) or PET vials (100 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 1 vial with 50 doses of freeze-dried powder and 1 vial with 100 ml of solvent.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Solvent: Colourless Type II glass vial (50 ml) or PET vials (50 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 1 vial with 25 doses of freeze-dried powder and 1 vial with 50 ml of solvent.
  • Freeze-dried powder: Colourless Type I glass vial closed with a bromobutyl rubber closure and an aluminium cap. Solvent: Colourless Type I glass vial (20 ml), or PET vials (20 ml) closed with a bromobutyl rubber closure and an aluminium cap. Package sizes: Intramuscular use: Cardboard box containing 1 vial with 10 doses of freeze-dried powder and 1 vial with 20 ml of solvent.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • LABORATORIOS HIPRA, S.A.
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • CY00401V
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0287/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 11/08/2025
Download